Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$1.7B
Avg Funding
$69.3M
Cities
22

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Lexington, United States
$2.5M
raised

iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Zug, Switzerland
$132.3M
raised

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hong Kong, Hong Kong

Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$10.0M
raised

Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ghent, Belgium
$14.1M
raised

Biotalys is an AgTech company that employs its proprietary AGROBODY™ technology platform to develop crop protection products.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Rockville, United States
$431.3M
raised

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States
$7.0M
raised

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paris, France
$45.0M
raised

Abivax develops medicines that alter the body's natural immune system mechanisms.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$150.0M
raised

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Rockville, United States
$11.0M
raised

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Houston, United States
$22.5M
raised

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Newton, United States
$2.8M
raised

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$55.0M
raised

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$276.0M
raised

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$74.2M
raised

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$2.0M
raised

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paramus, United States
$10.0M
raised

Polaryx Therapeutics is a biopharmaceutical company that provides molecule therapeutics development and clinical trial services.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$125.0M
raised

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

May 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Mateo, United States
$110.0M
raised

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

May 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$125.0M
raised

Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Saskatoon, Canada
$2.7M
raised

MustGrow Biologics is an agriculture biotech company providing natural, science-based biological solutions for crops.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.0M
raised

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Westfield, United States
$14.7M
raised

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$105.0M
raised

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

481 Biotechnology Post-IPO Equity Startups (September 2026) — Page 7 | VCBacked